Skip to main content

RT @JulianSegan: Sarilumab (IL-6R inhibitor) in phase 3 trial for relapsing PMR (SAPHYR trial). Key inclusion: Disease

Social Author Name
Julian Segan
Tweet Content
Sarilumab (IL-6R inhibitor) in phase 3 trial for relapsing PMR (SAPHYR trial). Key inclusion: Disease flare while taking >7.5mg prednisolone Sustained remission: resolution of symptoms, normalisation of CRP, adherence to prednisolone taper @RheumNow #ACR22 #Plenary

RT @RichardPAConway: Spiera et al. Sarilumab in refractory PMR (SAPHYR) - Phase 3 RCT. Significant effect of IL-6i. @Rhe

Social Author Name
Richard Conway
Tweet Content
Spiera et al. Sarilumab in refractory PMR (SAPHYR) - Phase 3 RCT. Significant effect of IL-6i. @RheumNow #ACR22 Abstr#1676 https://t.co/2MS441B8gU https://t.co/jBd7YJKrTs

RT @Janetbirdope: #ACR highlights - #pegloticase in #gout - less reactions and more benefit w #MTX MIRROR RCT. Better th

Social Author Name
Janet Pope
Tweet Content
#ACR highlights - #pegloticase in #gout - less reactions and more benefit w #MTX MIRROR RCT. Better than no MTX. Will change my practice - if I can access to a #peguricase, I will Rx w concomitant MTX Abst#0001 #ACR22 @RheumNow

RT @synovialjoints: Updated ACR Guidelines on Prevention and Rx of GIOP Rx recommendations when new fractures occur aft

Social Author Name
Dr. Antoni Chan
Tweet Content
Updated ACR Guidelines on Prevention and Rx of GIOP Rx recommendations when new fractures occur after 12 months of initial OP Rx https://t.co/TWdI728pCp Mary Beth Humphrey #ACR22 @RheumNow https://t.co/wHANvymd5R

RT @AurelieRheumo: PATCH study, 👁 safety data in children 5 yrs after birth In utero HCQ exposure does NOT: -impact

Social Author Name
Aurelie Najm
Tweet Content
PATCH study, 👁 safety data in children 5 yrs after birth In utero HCQ exposure does NOT: -impact retinal morphology (OCT) -reduce significantly retinal thickness https://t.co/D7SgPG6PX4 Abs#1647 #ACR22 @RheumNow

RT @RHEUMarampa: WE-CAN pragmatic RCT on community-dwelling ♂️&♀️ >/=50y w/ knee #osteoarthritis & ob

Social Author Name
sheila
Tweet Content
WE-CAN pragmatic RCT on community-dwelling ♂️&♀️ >/=50y w/ knee #osteoarthritis & obesity: 💠Diet + exercise = significant weight ⬇️and ☑️WOMAC pain score, WOMAC function, 6min walk distance & SF-36 HRQoL 🍽️+🚶‍♀️in OA? = Yes we can! #ACR22 @RheumNow @rheumarhyme https://t.co/Ty2boH52HC

RT @ericdeinmd: Ab1675 #ACR22 WE-CAN - Knee OA 823 randomized pts, 18 mo: Intensive Diet & Exercise (D+E) Primary en

Social Author Name
Eric Dein
Tweet Content
Ab1675 #ACR22 WE-CAN - Knee OA 823 randomized pts, 18 mo: Intensive Diet & Exercise (D+E) Primary endpt: WOMAC pain - 32% reduct in pain in D+E, vs 24% (PBO) 20% more likely: clinically meaningful improve Improved BMI, 6MW, HRQoL, activity Pain Rx, depression: no change @RheumNow https://t.co/Su2g4Z38FV

RT @Janetbirdope: Does diet & exercise work for knee pain in #osteoarthritis? Pragmatic trial in 3 community sites.

Social Author Name
Janet Pope
Tweet Content
Does diet & exercise work for knee pain in #osteoarthritis? Pragmatic trial in 3 community sites. 823 RCT, 80% completed -control was education &meetings vs diet&exercise;more intense. 101kg, 77% F, age 65. Diff modest-favoured diet & exercise-works a bit #ACR22 @RheumNow #1675 https://t.co/akjEjVprJl

RT @RHEUMarampa: Pain in #psoriaticarthritis might not be all inflammatory.. In this study presented by Dr F Sunzini: ð

Social Author Name
sheila
Tweet Content
Pain in #psoriaticarthritis might not be all inflammatory.. In this study presented by Dr F Sunzini: 👉PsA pts w/⬆️FM scores had⬆️functional brain connectivity bet mid-post IC & thalamus, phgyrus & PFC ..so consider nociplastic pain too & adjust mgt #ACR22 @RheumNow ABST#2256 https://t.co/suCAvx0pD5
Subscribe to
×